BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3510760)

  • 1. Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
    Harker LA
    Circulation; 1986 Feb; 73(2):206-23. PubMed ID: 3510760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion.
    Verstraete M; Brown BG; Chesebro JH; Ekeström S; Harker LA; Henderson AH; Jewitt DE; Oliver MF; Sleight P
    Eur Heart J; 1986 Jan; 7(1):4-13. PubMed ID: 3514223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet drugs in thromboembolism.
    Hirsh J
    Postgrad Med; 1979 Sep; 66(3):119-23, 126-7. PubMed ID: 382146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
    Turpie AG
    Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
    van der Meer J; Hillege HL; Kootstra GJ; Ascoop CA; Mulder BJ; Pfisterer M; van Gilst WH; Lie KI
    Lancet; 1993 Jul; 342(8866):257-64. PubMed ID: 8101300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet inhibitors in the treatment of thrombosis.
    Hirsh J
    Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
    [No Abstract]   [Full Text] [Related]  

  • 7. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion.
    Pfisterer M; Burkart F; Jockers G; Meyer B; Regenass S; Burckhardt D; Schmitt HE; Müller-Brand J; Skarvan K; Stulz P
    Lancet; 1989 Jul; 2(8653):1-7. PubMed ID: 2567792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-inhibitor therapy in cardiovascular disease. Effective defense against thromboembolism.
    Chesebro JH; Steele PM; Fuster V
    Postgrad Med; 1985 Jul; 78(1):48-50, 57-71. PubMed ID: 3160013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are agents affecting platelet functions clinically useful?
    Verstraete M
    Am J Med; 1976 Dec; 61(6):897-914. PubMed ID: 795299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease.
    Fuster V; Chesebro JH
    Circulation; 1986 Feb; 73(2):227-32. PubMed ID: 3510762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
    Hirsh J
    Arch Intern Med; 1981 Feb; 141(3 Spec No):311-5. PubMed ID: 7008733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of antithrombotic drugs in artery disease.
    Gallus AS
    Clin Haematol; 1986 May; 15(2):509-59. PubMed ID: 3524934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet inhibition in the management of thrombosis.
    Didisheim P; Kazmier FJ; Fuster V
    Thromb Diath Haemorrh; 1974 Sep; 32(1):21-34. PubMed ID: 4616423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS
    Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
    Cairns JA
    Cardiovasc Clin; 1987; 18(1):231-46. PubMed ID: 3300983
    [No Abstract]   [Full Text] [Related]  

  • 16. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts.
    Stein PD; Dalen JE; Goldman S; Théroux P
    Chest; 1998 Nov; 114(5 Suppl):658S-665S. PubMed ID: 9822069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
    Aronow WS
    Drugs Aging; 1999 Aug; 15(2):91-101. PubMed ID: 10495069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-inhibitory therapy in reconstructive arterial surgery.
    McCollum CN; Goldman M
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():301-9. PubMed ID: 3159216
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of platelet inhibitor therapy in myocardial infarction.
    Stein B; Fuster V
    Cardiovasc Drugs Ther; 1989 Dec; 3(6):797-813. PubMed ID: 2487543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelets and platelet-inhibitor drugs in aortocoronary vein bypass operations.
    Chesebro JH; Fuster V
    Int J Cardiol; 1983; 2(5-6):511-6. PubMed ID: 6341260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.